WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 8 fonti

It Kinda Looks Like Trump Might Be Taking An Experimental Obesity Drug?

Retatrutide has not been approved by the FDA, but precisely one 79-year-old man was granted access via "compassionate use."

Raccontata danewrepublic.comstatnews.commedpagetoday.comarstechnica.comhuffpost.comgizmodo.comnymag.comindependent.co.uk

Confronto fonti

6 prospettive sulla stessa storia
AI · summaries
huffpost.comStai leggendo1 g fa

It Kinda Looks Like Trump Might Be Taking An Experimental Obesity Drug?

Retatrutide has not been approved by the FDA, but precisely one 79-year-old man was granted access via "compassionate use."

originale
newrepublic.com2 g fa

Eli Lilly Approved Obesity Drug for Mystery 79-Year-Old Patient

Questions are swirling over Donald Trump’s health after a bombshell report revealed a mystery man was getting unprecedented access to a weight-loss drug.

Leggi questa versione → originale
gizmodo.com1 g fa

Just Who Is the Mystery 79-Year-Old Patient Who Got Special Access to an Experimental Weight Loss Drug?

The White House has denied that the application was filed on behalf of President Donald Trump.

Leggi questa versione → originale
arstechnica.com1 g fa

Trump may be mystery patient in odd case of 79yo getting experimental obesity drug

Public notice of a single "compassionate use" case is odd in every way.

Leggi questa versione → originale
statnews.com2 g fa

Eli Lilly gave extraordinary obesity drug access to a 79-year-old patient. Who was it?

Exclusive: STAT has learned that Eli Lilly and the FDA allowed a 79-year-old to gain extraordinary access to an experimental obesity drug through the agency’s “compassionate use” program.

Leggi questa versione → originale
medpagetoday.com2 g fa

White House Denies Trump Got Unapproved Obesity Drug

Compassionate use of retatrutide granted for someone with sleep apnea, pulmonary hypertension

Leggi questa versione → originale

Timeline cronologica

  1. martedì 23 giugno 2026·newrepublic.com

    Eli Lilly Approved Obesity Drug for Mystery 79-Year-Old Patient

    Questions are swirling over Donald Trump’s health after a bombshell report revealed a mystery man was getting unprecedented access to a weight-loss drug.

  2. martedì 23 giugno 2026·newrepublic.com

    Remember That Time Trump Said He “Probably Should” Take Ozempic?

    A bombshell report about how a 79-year-old man got early access to a weight loss drug has all eyes on the president.

  3. martedì 23 giugno 2026·statnews.com

    Eli Lilly gave extraordinary obesity drug access to a 79-year-old patient. Who was it?

    Exclusive: STAT has learned that Eli Lilly and the FDA allowed a 79-year-old to gain extraordinary access to an experimental obesity drug through the agency’s “compassionate use”…

  4. martedì 23 giugno 2026·medpagetoday.com

    White House Denies Trump Got Unapproved Obesity Drug

    Compassionate use of retatrutide granted for someone with sleep apnea, pulmonary hypertension

  5. martedì 23 giugno 2026·arstechnica.com

    Trump may be mystery patient in odd case of 79yo getting experimental obesity drug

    Public notice of a single "compassionate use" case is odd in every way.

  6. martedì 23 giugno 2026·huffpost.com

    It Kinda Looks Like Trump Might Be Taking An Experimental Obesity Drug?

    Retatrutide has not been approved by the FDA, but precisely one 79-year-old man was granted access via "compassionate use."

  7. martedì 23 giugno 2026·gizmodo.com

    Just Who Is the Mystery 79-Year-Old Patient Who Got Special Access to an Experimental Weight Loss Drug?

    The White House has denied that the application was filed on behalf of President Donald Trump.

  8. martedì 23 giugno 2026·nymag.com

    Did Trump Get Early Access to Eli Lilly’s New Weight-Loss Drug?

    The FDA let one 79-year-old take an experimental obesity drug. That sure sounds like the president, but let’s examine the evidence.

  9. mercoledì 24 giugno 2026·independent.co.uk

    White House denies Trump was mystery patient given early access to weight-loss drug

    Stay up to date with notifications from The IndependentNotifications can be managed in browser preferences.AllNewsSportCultureLifestyleWhite House officials are denying that…